Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of tax conjugation to ubiquitin and SUMO

Journal of Virology

Volumn 87, Issue 2, 2013, Pages 1123-1136

  Journo, Chloé ^a,b   Bonnet, Amandine ^c,d   Favre bonvin, Arnaud ^c,d   Turpin, Jocelyn ^a,b   Vinera, Jennifer ^a,b   Côté, Emilie ^a,b   Chevalier, Sébastien Alain ^a,b   Kfoury, Youmna ^e   Bazarbachi, Ali ^e   Pique, Claudine ^c,d   Mahieux, Renaud ^a,b  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSTITUT COCHIN   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUMO PROTEIN; TAX PROTEIN; TAX1 PROTEIN; TAX2 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME 13; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HELA CELL; HUMAN T CELL LEUKEMIA VIRUS 2; LEUKEMIA CELL LINE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SUMOYLATION; UBIQUITINATION;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 84871999611     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01792-12     Document Type: Article

References (71)

1. Feuer G, Green PL. 2005. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24:5996-6004.
2. Anonymous. 1988. The third nation-wide study on adult T-cell leukemia/ lymphoma (ATL) in Japan: characteristic patterns of HLA antigen and HTLV-I infection in ATL patients and their relatives. The T-and B-cell Malignancy Study Group. Int. J. Cancer 41:505-512.
3. Takatsuki T. 1977. Adult T-cell leukemia in Japan, p 73-77. In Seno S, Irino S (ed), Topics in hematology. Excerpta Medica, Amsterdam, The Netherlands.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
5. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031-1032.
6. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G. 1992. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339:645-646.
7. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. 1993. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-Iassociated myelopathy/tropical spastic paraparesis. Ann. Neurol. 33:392-396.
8. Easley R, Carpio L, Guendel I, Klase Z, Choi S, Kehn-Hall K, Brady JN, Kashanchi F. 2010. Human T-lymphotropic virus type 1 transcription and chromatin-remodeling complexes. J. Virol. 84:4755-4768.
9. Kannian P, Green PL. 2010. Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis. Viruses 2:2037-2077.
10. Matsuoka M, Jeang KT. 2007. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7:270-280.
11. Higuchi M, Fujii M. 2009. Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 6:117.
12. Semmes OJ, Majone F, Cantemir C, Turchetto L, Hjelle B, Jeang KT. 1996. HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs. Virology 217:373-379.
13. Tripp A, Banerjee P, Sieburg M, Planelles V, Li F, Feuer G. 2005. Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34γ) cells: modulation of p21cip1/ waf1 and p27kip1 expression. J. Virol. 79:14069-14078.
14. Tripp A, Liu Y, Sieburg M, Montalbano J, Wrzesinski S, Feuer G. 2003. Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34γcells in vitro. J. Virol. 77:12152-12164.
15. Hirata A, Higuchi M, Niinuma A, Ohashi M, Fukushi M, Oie M, Akiyama T, Tanaka Y, Gejyo F, Fujii M. 2004. PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein augments the transforming activity in a rat fibroblast cell line. Virology 318:327-336.
16. Bex F, McDowall A, Burny A, Gaynor R. 1997. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 71:3484-3497.
17. Bex F, Yin MJ, Burny A, Gaynor RB. 1998. Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol. Cell. Biol. 18:2392-2405.
18. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. 1985. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229:675-679.
19. Semmes OJ, Jeang KT. 1996. Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J. Virol. 70:6347-6357.
20. Slamon DJ, Boyle WJ, Keith DE, Press MF, Golde DW, Souza LM. 1988. Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I. J. Virol. 62:680-686.
21. Harhaj NS, Sun SC, Harhaj EW. 2007. Activation of NF-kappa B by the human T cell leukemia virus type I Tax oncoprotein is associated with ubiquitin-dependent relocalization of I kappa B kinase. J. Biol. Chem. 282:4185-4192.
22. Kfoury Y, Nasr R, Favre-Bonvin A, El-Sabban M, Renault N, Giron ML, Setterblad N, Hajj HE, Chiari E, Mikati AG, Hermine O, Saib A, de The H, Pique C, Bazarbachi A. 2008. Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome. Oncogene 27:1665-1676.
23. Lamsoul I, Lodewick J, Lebrun S, Brasseur R, Burny A, Gaynor RB, Bex F. 2005. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell. Biol. 25:10391-10406.
24. Nejmeddine M, Barnard AL, Tanaka Y, Taylor GP, Bangham CR. 2005. Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 280:29653-29660.
25. Meertens L, Chevalier S, Weil R, Gessain A, Mahieux R. 2004. A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution. J. Biol. Chem. 279:43307-43320.
26. Sheehy N, Lillis L, Watters K, Lewis M, Gautier V, Hall W. 2006. Functional analysis of human T lymphotropic virus type 2 Tax proteins. Retrovirology 3:20.
27. Turci M, Lodewick J, Righi P, Polania A, Romanelli MG, Bex F, Bertazzoni U. 2009. HTLV-2B Tax oncoprotein is modified by ubiquitination and sumoylation and displays intracellular localization similar to its homologue HTLV-1 Tax. Virology 386:6-11.
28. Turci M, Romanelli MG, Lorenzi P, Righi P, Bertazzoni U. 2006. Localization of human T-cell lymphotropic virus type II Tax protein is dependent upon a nuclear localization determinant in the N-terminal region. Gene 365:119-124.
29. Bertazzoni U, Turci M, Avesani F, Di Gennaro G, Bidoia C, Romanelli MG. 2011. Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences. Viruses 3:541-560.
30. Alefantis T, Barmak K, Harhaj EW, Grant C, Wigdahl B. 2003. Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax. J. Biol. Chem. 278:21814-21822.
31. Chevalier SA, Meertens L, Calattini S, Gessain A, Kiemer L, Mahieux R. 2005. Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein. Retrovirology 2:70.
32. Burton M, Upadhyaya CD, Maier B, Hope TJ, Semmes OJ. 2000. Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets. J. Virol. 74:2351-2364.
33. Nicot C, Tie F, Giam CZ. 1998. Cytoplasmic forms of human T-cell leukemia virus type 1 Tax induce NF-kappaB activation. J. Virol. 72:6777-6784.
34. Luo JL, Kamata H, Karin M. 2005. The anti-death machinery in IKK/ NF-kappaB signaling. J. Clin. Immunol. 25:541-550.
35. Oeckinghaus A, Hayden MS, Ghosh S. 2011. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12:695-708.
36. Avesani F, Romanelli MG, Turci M, Di Gennaro G, Sampaio C, Bidoia C, Bertazzoni U, Bex F. 2010. Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-kappaB activation. Virology 408:39-48.
37. Endo K, Hirata A, Iwai K, Sakurai M, Fukushi M, Oie M, Higuchi M, Hall WW, Gejyo F, Fujii M. 2002. Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax. J. Virol. 76:2648-2653.
38. Higuchi M, Tsubata C, Kondo R, Yoshida S, Takahashi M, Oie M, Tanaka Y, Mahieux R, Matsuoka M, Fujii M. 2007. Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line. J. Virol. 81:11900-11907.
39. Ross TM, Minella AC, Fang ZY, Pettiford SM, Green PL. 1997. Mutational analysis of human T-cell leukemia virus type 2 Tax. J. Virol. 71: 8912-8917.
40. Ross TM, Narayan M, Fang ZY, Minella AC, Green PL. 2000. Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells. J. Virol. 74:2655-2662.
41. Shoji T, Higuchi M, Kondo R, Takahashi M, Oie M, Tanaka Y, Aoyagi Y, Fujii M. 2009. Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2. Retrovirology 6:83.
42. Hayden MS, Ghosh S. 2008. Shared principles in NF-kappaB signaling. Cell 132:344-362.
43. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A. 1998. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93:1231-1240.
44. Fu J, Qu Z, Yan P, Ishikawa C, Aqeilan RI, Rabson AB, Xiao G. 2011. The tumor suppressor geneWWOXlinks the canonical and noncanonical NF-kappaB pathways in HTLV-I Tax-mediated tumorigenesis. Blood 117:1652-1661.
45. Journo C, Douceron E, Mahieux R. 2009. HTLV gene regulation: because size matters, transcription is not enough. Future Microbiol. 4:425-440.
46. Yamamoto K, Ishida T, Nakano K, Yamagishi M, Yamochi T, Tanaka Y, Furukawa Y, Nakamura Y, Watanabe T. 2011. SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax. Cancer Sci. 102:260-266.
47. Yasunaga J, Lin FC, Lu X, Jeang KT. 2011. Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J. Virol. 85:6212-6219.
48. Sun SC, Yamaoka S. 2005. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 24:5952-5964.
49. Chiari E, Lamsoul I, Lodewick J, Chopin C, Bex F, Pique C. 2004. Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J. Virol. 78:11823-11832.
50. Gatza ML, Dayaram T, Marriott SJ. 2007. Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export. Retrovirology 4:95.
51. Kfoury Y, Setterblad N, El-Sabban M, Zamborlini A, Dassouki Z, El Hajj H, Hermine O, Pique C, de The H, Saib A, Bazarbachi A. 2011. Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome. Blood 117:190-199.
52. Nasr R, Chiari E, El-Sabban M, Mahieux R, Kfoury Y, Abdulhay M, Yazbeck V, Hermine O, de The H, Pique C, Bazarbachi A. 2006. Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood 107:4021-4029.
53. Peloponese JM, Jr, Iha H, Yedavalli VR, Miyazato A, Li Y, Haller K, Benkirane M, Jeang KT. 2004. Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity. J. Virol. 78:11686-11695.
54. Lodewick J, Lamsoul I, Bex F. 2011. Move or die: the fate of the Tax oncoprotein of HTLV-1. Viruses 3:829-857.
55. Shembade N, Harhaj EW. 2010. Role of post-translational modifications of HTLV-1 Tax in NF-kappaB activation. World J. Biol. Chem. 1:13-20.
56. Bonnet A, Randrianarison-Huetz V, Nzounza P, Nedelec M, Chazal M, Waast L, Pene S, Bazarbachi A, Mahieux R, Benit L, Pique C. 2012. Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation. Retrovirology 9:77.
57. Shembade N, Harhaj NS, Yamamoto M, Akira S, Harhaj EW. 2007. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J. Virol. 81: 13735-13742.
58. Fryrear KA, Guo X, Kerscher O, Semmes OJ. 2011. The SUMO-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax. Blood 119:1173-1181.
59. Yan P, Fu J, Qu Z, Li S, Tanaka T, Grusby MJ, Xiao G. 2009. PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood 113:4370-4380.
60. Hjerpe R, Rodriguez MS. 2008. Efficient approaches for characterizing ubiquitinated proteins. Biochem. Soc. Trans. 36:823-827.
61. Smith MR, Greene WC. 1990. Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875-1885.
62. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351-361.
63. Gentry JJ, Rutkoski NJ, Burke TL, Carter BD. 2004. A functional interaction between the p75 neurotrophin receptor interacting factors, TRAF6 and NRIF. J. Biol. Chem. 279:16646-16656.
64. Coulombe P, Rodier G, Bonneil E, Thibault P, Meloche S. 2004. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol. Cell. Biol. 24:6140-6150.
65. Lodewick J, Lamsoul I, Polania A, Lebrun S, Burny A, Ratner L, Bex F. 2009. Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. Virology 386:68-78.
66. Gao M, Karin M. 2005. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol. Cell 19:581-593.
67. Durkin SS, Ward MD, Fryrear KA, Semmes OJ. 2006. Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein. J. Biol. Chem. 281:31705-31712.
68. Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, Shaik S, Wan L, Ang XL, Mock C, Yin H, Stommel JM, Gygi S, Lahav G, Asara J, Xiao ZX, Kaelin WG, Jr, Harper JW, Wei W. 2010. Phosphorylation by casein kinase I promotes the turnover of theMdm2oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 18:147-159.
69. Wilkinson KA, Henley JM. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 428:133-145.
70. Xiao G, Harhaj EW, Sun SC. 2000. Domain-specific interaction with the I kappa B kinase (IKK) regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK. J. Biol. Chem. 275:34060-34067.
71. Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, Daakour S, Klitgord N, Martin M, Willaert JF, Dequiedt F, Navratil V, Cusick ME, Burny A, Van Lint C, Hill DE, Tavernier J, Kettmann R, Vidal M, Twizere JC. 2012. Host-pathogen interactome mapping for HTLV-1 and 2 retroviruses. Retrovirology 9:26.